SCHEMBL20127360

SCHEMBL20127360

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)oc4cc(-c6ccc7ccccc7c6)c6ccccc6c45)c4ccccc34)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.40
GPR84 Q9NQS5 1/20 0.40
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
MIF P14174 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HCRTR1 O43613 1/20 0.36
NOTUM Q6P988 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PRKDC P78527 1/20 0.34
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127352 0.94 GPR84 (0.39) GSTP1GPR84CYP1A1CYP1B1MIF
SCHEMBL20127353 0.93 GPR84 (0.38) GSTP1GPR84CYP1A1CYP1B1MIF
SCHEMBL13507104 0.93 CYP1A1 (0.41) GSTP1GPR84CYP1A1CYP1B1HCRTR1
SCHEMBL20127355 0.92 HCRTR1 (0.37) GSTP1GPR84CYP1A1CYP1B1MIF
SCHEMBL19080096 0.91 GSTP1 (0.40) GSTP1GPR84CYP1A1CYP1B1MIF
SCHEMBL20127354 0.90 MAPK9 (0.42) CYP1A1CYP1B1NOTUMCYP1A2SMN1; SMN2
SCHEMBL17943908 0.89 GPR84 (0.39) GSTP1GPR84CYP1A1CYP1B1MIF
SCHEMBL20127351 0.89 GPR84 (0.40) GSTP1GPR84CYP1A1CYP1B1MIF
SCHEMBL17931938 0.89 TDP1 (0.38) GSTP1GPR84CYP1A1CYP1B1MIF
SCHEMBL13507287 0.89 CYP1A1 (0.40) GPR84CYP1A1CYP1B1HCRTR1NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 GSTP1 2505/4885GPR84 2389/4885CYP1A1 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.